Dual Functionality of [ 64 Cu]Cu-NOTA-San A-Cy7 for Diagnostic Imaging and Surgical Guidance in Hsp90α-Positive Tumors
Molecular Pharmaceutics · 2025
DOI: 10.1021/acs.molpharmaceut.5c00126 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Zhijun Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong Provi…. Hauptthemen laut MEDLINE: HSP90 Heat-Shock Proteins, Copper Radioisotopes, Esophageal Neoplasms. Die Arbeit nennt 44 Literaturangaben. Gefördert von: Sun Yat-sen University, National Key Research and Development Program of China, Special Project for Research and Development in Key areas of Guangdong Province.
Abstract (Originalsprache)
Intraoperative fluorescence navigation in esophageal cancer enables the clinical translation of fluorescence imaging. Heat shock protein 90 alpha (Hsp90α) plays a vital role in the progression of malignant disease, and elevated Hsp90α expression has been reported in esophageal cancer. The aim of this study was to develop a dual-modality probe, [64Cu]Cu-NOTA-San A-Cy7, for imaging Hsp90α expression in vivo via both positron emission tomography (PET) and fluorescence imaging in esophageal cancer. In this study, the Hsp90α-targeting cyclopeptide Sansalvamide A (San A) was chemically modified with a Cy7 dye and NOTA chelator simultaneously. Experimental assays confirmed that NOTA-San A-Cy7 has a favorable affinity for Hsp90α-positive EC109 cells, with a dissociation constant (Kd) of 1.08 ± 0.19 μM. The probe [64Cu]Cu-NOTA-San A-Cy7 was successfully synthesized with 64CuCl2, achieving a high radiochemical purity of over 95%. Furthermore, the probe demonstrated excellent stability in both saline and serum solutions. The probe was subsequently evaluated in a Hsp90α-positive EC109 tumor-bearing model via PET imaging, which confirmed that Hsp90α-specific uptake was significantly reduced by the co-administration of an excess blocking agent. Biodistribution studies revealed that at 24 hours post-injection, the tumor uptake of the probe was 1.35 ± 0.29%ID/g in the nonblocking group and significantly decreased to 0.73 ± 0.15%ID/g in the blocking group (p < 0.05). Concurrent with the PET experiment, fluorescence imaging was conducted, revealing substantial tumor uptake in the EC109 model. As a proof of concept, imaging-guided surgery utilizing the fluorescent component of this probe was performed. This approach demonstrated the potential for providing surgical guidance in mice positive for Hsp90α, highlighting the dual functionality of the probe for both diagnostic imaging and intraoperative navigation. In summary, our findings unequivocally demonstrate that the dual-modality probe [64Cu]Cu-NOTA-San A-Cy7 holds significant promise as an agent for imaging Hsp90α-positive tumors in vivo, offering a valuable tool for the detection and potential management of such tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong Province 519000, China.
- Department of Urology, The Second Affiliated Hospital, University of South China, Hengyang, Hunan Province 421001, China.
- Department of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510000, China.
- Department of Nuclear Medicine, The First Hospital of Lanzhou University, Lanzhou 730000, China.
ORCID-Profile: Xiaohui Wang, Hongjun Jin
Förderung
- Sun Yat-sen University
- National Key Research and Development Program of China
- Special Project for Research and Development in Key areas of Guangdong Province
- Basic and Applied Basic Research Foundation of Guangdong Province
- Lanzhou Science and Technology Bureau
- Fundo para o Desenvolvimento das Ci?ncias e da Tecnologia
- National Natural Science Foundation of China
- Hunan National Science Foundation-Regional Joint Fund
Zitieren
APA
Li, Z., Peng, T., Yang, M., Qiu, Y., Ye, P., Wang, X., & Jin, H. (2025). Dual Functionality of [ 64 Cu]Cu-NOTA-San A-Cy7 for Diagnostic Imaging and Surgical Guidance in Hsp90α-Positive Tumors. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c00126
Vancouver
Li Z, Peng T, Yang M, Qiu Y, Ye P, Wang X, et al. Dual Functionality of [ 64 Cu]Cu-NOTA-San A-Cy7 for Diagnostic Imaging and Surgical Guidance in Hsp90α-Positive Tumors. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.5c00126
BibTeX
@article{Li2025,
author = {Li, Zhijun and Peng, Tukang and Yang, Min and Qiu, Yifan and Ye, Peizhen and Wang, Xiaohui and Jin, Hongjun},
title = {Dual Functionality of [ 64 Cu]Cu-NOTA-San A-Cy7 for Diagnostic Imaging and Surgical Guidance in Hsp90α-Positive Tumors},
journal = {Molecular Pharmaceutics},
year = {2025},
doi = {10.1021/acs.molpharmaceut.5c00126}
}
EUVIMED